BIO-TECHNE Corp - 8-K Filing

Bio-Techne declares $0.08 per share quarterly cash dividend contingent on Merck KGaA transaction status (Items: 8.01 Other EventsA copy of the press release issued by Bio-Techne Corporation on November 3, 2026, announcing a cash dividend is attached hereto, 9.01 Financial Statements and Exhibits(d) Exhibits 99)

SEC EDGAR · November 4, 2026, 11:03 UTC

Tickers: $TECH

Read the full article at SEC EDGAR

More Regulatory news

Applied Aerospace & Defense, Inc. - 10-Q Filing SEC EDGAR · November 12, 2026, 14:02 UTC
Palomar Holdings, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 14:02 UTC
UNITED GUARDIAN INC - 10-Q Filing SEC EDGAR · November 12, 2026, 14:00 UTC
Dare Bioscience, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 14:00 UTC
NEXGEL, INC. - 8-K Filing SEC EDGAR · November 12, 2026, 14:00 UTC
TEREX CORP - 8-K Filing SEC EDGAR · November 12, 2026, 14:00 UTC
Victory Capital Holdings, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 13:59 UTC
Nano Dimension Ltd. - 8-K Filing SEC EDGAR · November 12, 2026, 13:59 UTC
M-tron Industries, Inc. - 10-Q Filing SEC EDGAR · November 12, 2026, 13:56 UTC
M-tron Industries, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 13:55 UTC